As you seek to learn more about Oracle Health Sciences and explore opportunities to help Gilead accelerate clinical trials and support patient outcomes, please feel free to call on me at any time. We are at your service!
Sponsors and CROs face intense pressure to speed clinical trials and restrain costs, but current industry processes are inadequate at helping stakeholders spot risk factors and bottlenecks that can disrupt cycle times and budgets. Oracle’s Health Sciences suite of clinical forecasting, study startup, site feasibility, data collection, RTSM, trial management, risk assessment, and safety solutions can help.
How we engage with Gilead: Key Tenants of our Health Sciences partnership and engagement model:
- Ongoing executive alignment to oversee success
- Keep our dialogue open, informal, meaningful, trusting
- Measurable goals & outcomes to support decision making
- Highlight joint wins & challenges
- Collaborative process – in it together!
As a preview to our clinical innovation, below are two sample presentations on key topics relevant to Gilead, in addition, you may learn more about Clinical One here.
Please feel free to reach out to me at Joy.Haugen@oracle.com or my cell 949.887.7188.
Email Me
Have A Question?
Connect with me on LinkedIn
Share this site with a Gilead colleague
Oracle’s completes acquisition of Cerner: Readies for the future of healthcare
Prioritizing outcomes in healthcare is long overdue and now within reach following Oracle’s acquisition of Cerner. To achieve more seamless, coordinated care, technology must play a greater role in reframing solutions for health and well-being around the world.
Combining Cerner’s clinical capabilities with Oracle’s enterprise platform, analytics, and automation expertise will change health and wellness in a way that simply hasn’t been possible before.
For an update on Oracle’s Health Sciences strategy and the Cerner acquisition, contact me.
NEXT GENERATION STUDY DESIGN
Powering Your Digital, Hybrid, And Decentralized Clinical Trials
The COVID-19 pandemic ignited the shift toward new clinical trial approaches and technologies. Explore what's available to help you adopt these new clinical trial approaches at your organization.
STUDY STARTUP
EU Set To Attract More Clinical Trials With Streamlined Submission Process
Patients can be assured that their prescribed medicine has been vetted for safety and efficacy by a long and arduous discovery process guided by governmental regulatory agencies. The European Union (EU) recorded a concerning 25% decrease in clinical trial applications (CTAs) from 2007 to 2011, and this downward trend has continued. Find out why.
To chat about our study start up solutions, you may contact me here.
DATA COLLECTION
Regulatory Hurdles For Decentralized Trials: A European Perspective
As COVID-19 began spreading across the globe, life science companies began to accelerate the adoption of decentralized clinical trial methods, such as telemedicine visits and remote data collection. However, the ambiguity of regulatory guidance for these trial types is one of the major challenges.
For more information or a demo of Clinical One, you may contact me here.
Did you know you can run Oracle CTMS on-premise or in the Cloud? Contact me here to learn more.
STUDY PLANNING & BUDGETING
Are you a Gilead ClearTrial user? Find the latest ClearTrial 5.9 Release Notes here and supplemental guide here (your ClearTrial Login required).
Upcoming Workshop
Stay tuned for the Gilead ClearTrial User Workshop taking place soon! More information to follow from
your Gilead ClearTrial system owners on a workshop date forthcoming. In the meantime, feel free to
reach out with any questions via email to Kristin.ludwig@oracle.com.
Sign up to our new ClearTrial community forum – COMING SOON!
NEXT-GENERATION SAFETY
Oracle and Gilead are collaborating on the future of Safety AI and Automations. Please stay tuned for more information, or reach out to vick.dilawari@gilead.com or joy.haugen@oracle.com for additional information on our progress.
THOUGHT LEADERSHIP
Oracle Health Sciences Connect 2022
Replay of sessions available now! Register here to view the agenda and event recordings. Sample sessions include:
- Embrace the future: innovation at the speed of science
- Integrating sensor generated data to power clinical research and patient care
- The next Decentralized Clinical Trial (DCT) frontier
- Modern comprehensive pharmacovigilance
The Latest Dose
The podcast that explores the depths of innovation and human compassion in clinical research. Listen and Subscribe Here.
Recent Webinars
PRESS ANNOUNCEMENTS
